Fluphenazine Inj

— THERAPEUTIC CATEGORIES —
  • Psychosis

Fluphenazine Inj Generic Name & Formulations

General Description

Fluphenazine HCl 2.5 mg/mL; vial.

Pharmacological Class

Piperazine phenothiazine.

How Supplied

Contact supplier.

Fluphenazine Inj Indications

Indications

Psychosis.

Fluphenazine Inj Dosage and Administration

Adult

Initially: 1.25mg IM every 6–8 hrs; max 10mg daily.

Children

Not recommended.

Fluphenazine Inj Contraindications

Contraindications

Coma. CNS or bone marrow depression. Liver disease. Subcortical brain damage. Blood dyscrasias.

Fluphenazine Inj Boxed Warnings

Not Applicable

Fluphenazine Inj Warnings/Precautions

Warnings/Precautions

Cardiovascular or renal disease. Pheochromocytoma. Seizures. Glaucoma. History of breast cancer. Exposure to extreme heat or organophosphates. Gradually reduce to lowest effective maintenance dose. Monitor blood, liver, renal, and ocular function. Mental retardation. Surgery. Pregnancy. Nursing mothers.

Fluphenazine Inj Pharmacokinetics

See Literature

Fluphenazine Inj Interactions

Interactions

Potentiates anticholinergics, CNS depression with alcohol and other CNS depressants; both drugs with propranolol. Antagonized by anticholinergics. Decreased guanethidine effects. May cause false (+) pregnancy test.

Fluphenazine Inj Adverse Reactions

Adverse Reactions

Drowsiness, anticholinergic and other autonomic effects, insomnia, restlessness, rash, photosensitivity, tardive dyskinesia, blood dyscrasias, jaundice, pneumonia, hypertension, retinopathy, lowered seizure threshold, extrapyramidal reactions, neuroleptic malignant syndrome, weight changes, endocrine effects.

Fluphenazine Inj Clinical Trials

See Literature

Fluphenazine Inj Note

Notes

Formerly known under the brand names Prolixin (tabs, concentrate, elixir, inj); Permitil (tabs, concentrate); Prolixin Decanoate (decanoate inj).

Fluphenazine Inj Patient Counseling

See Literature